Balaxi Pharmaceuticals Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Dec '23
Sep '23
Jun '23
Mar '23
Dec '22
Total Qtr Revenue cr
60.65
55.00
64.95
80.46
82.02
Other Income Qtr Cr-0.130.28-1.01-0.22-4.57
Operating Revenues Qtr60.7954.7265.9680.6886.58

*All values are in Cr.

Operating Expenses Qtr
47.13
43.96
57.12
67.94
71.29
Operating Profit Qtr
13.66
10.76
8.84
12.74
15.29
EBIDT Qtr Cr
15.17
16.69
-38.84
12.52
10.73
Depreciation Qtr
0.48
0.66
0.29
1.19
0.19
Net Profit Qtr
13.59
14.43
-41.34
8.10
8.23
Basic EPS Qtr
13.29
14.10
-40.49
8.01
8.21
Open Demat Account
or Resume your Application
+91 -

personImage